Get the Stockscreener App
0.601
3.98%
0.023
After Hours:
.59
-0.011
-1.83%
VolitionRX Ltd stock is traded at $0.601, with a volume of 128.54K.
It is up +3.98% in the last 24 hours and down -16.53% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.578
Open:
$0.5897
24h Volume:
128.54K
Relative Volume:
0.98
Market Cap:
$54.34M
Revenue:
$775.30K
Net Income/Loss:
$-35.32M
P/E Ratio:
-1.0732
EPS:
-0.56
Net Cash Flow:
$-19.15M
1W Performance:
-3.22%
1M Performance:
-16.53%
6M Performance:
-20.61%
1Y Performance:
-12.77%
1-Day Range:
$0.5731
$0.61
1-Week Range:
$0.56
$0.65
52-Week Range:
$0.4301
$1.23
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow
VolitionRx announces executive employment updates - Investing.com India
Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY
Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times
Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend
Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week
Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse
Volato Facing Class-action WARN Act Lawsuit - Aviation International News
VolitionRx offers oncology assets for licensing - Investing.com India
VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia
Volition Announces Board of Directors - TechBuzz News
CRYPTOPSY's New Shirts Are Very Serious - Metal Injection
Terminated Volato Employees File Class Action Lawsuit - FLYING
LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24
Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily
Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance
VolitionRX Ltd [VNRX] Records 200-Day SMA of $0.7821 - Knox Daily
The Potential Rise in the Price of VolitionRX Ltd (VNRX) following insiders activity - Knox Daily
Understanding the Risks of Investing in VolitionRX Ltd (VNRX) - Knox Daily
Comparing OncoCyte (NASDAQ:OCX) & VolitionRx (NYSE:VNRX) - Defense World
VolitionRx (NYSEAMERICAN:VNRX) Stock Price Passes Above 50-Day Moving Average of $0.00 - Defense World
VolitionRx Limited (NYSE:VNRX) Director Guy Archibald Innes Purchases 150,000 Shares - Defense World
VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlight - GuruFocus.com
Benchmark Reiterates Hold Rating for VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Limited (AMEX:VNRX) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: VolitionRx reports strong growth and optimistic outlook - Investing.com
VolitionRX: Q2 Earnings Snapshot - San Antonio Express-News
VolitionRX: Q2 Earnings Snapshot - The Washington Post
VolitionRX: Q2 Earnings Snapshot - New Haven Register
VolitionRX: Q2 Earnings Snapshot - San Francisco Chronicle
VolitionRX: Q2 Earnings Snapshot - CTPost
Market Highlights: VolitionRX Ltd (VNRX) Ends on a Low Note at 0.53 - The Dwinnex
Form 424B5 VOLITIONRX LTD - StreetInsider.com
SEC Form 424B5 filed by VolitionRX Limited - Quantisnow
VolitionRx announces $7 million stock and warrant sale - Investing.com India
VolitionRx (NYSEAMERICAN:VNRX) Share Price Passes Above 50 Day Moving Average of $0.00 - Defense World
VNRX Stock Touches 52-Week Low at $0.55 Amid Market Challenges - Investing.com
VolitionRx (NYSEAMERICAN:VNRX) Shares Pass Above Fifty Day Moving Average of $0.00 - Defense World
VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World
Head And Neck Cancer Diagnostics Market Growth Analysis With Investment Opportunities - EIN News
Virax Biolabs Group (NASDAQ:VRAX) & VolitionRx (NYSE:VNRX) Head-To-Head Review - Defense World
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing - StockTitan
Envela Corp shareholders elect board, ratify auditor By Investing.com - Investing.com India
VolitionRx expands stock plan and authorized shares By Investing.com - Investing.com India
StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts - Quantisnow
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting - StockTitan
Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation - Quantisnow
Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network - Quantisnow
Volition Appoints Mickie Henshall as an Independent Director - Quantisnow
Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar - Quantisnow
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):